Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01928550 · ClinicalTrials.gov registry record
Diabetes PRP and OCT
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 8
- Enrollment target
NCT01928550: Completed study, sponsored by Oregon Health and Science University.
NCT01928550 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01928550 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of investigational Doppler Optical Coherence Tomography (OCT) and OCT angiography in the management of proliferative diabetic retinopathy (PDR - a leading cause of blindness in diabetic patients) before and after treatment. Angiography is the mapping of the blood vessels, and Doppler detects blood flow. PDR is due to poor oxygen circulation in smaller blood vessels in the back of the eye (retina), and is observed in 80% of people who have had diabetes for more than 10 years. This study will look at how blood flow to the eye is affected before and after treatment.
Primary Outcome
1\) Total retinal blood flow, as measured by Doppler OCT, will be correlated with visual acuity and the severity of PDR. This will be performed by the following analysis: 1. Pearson's correlation test of total retinal blood flow with logMAR (Logarithm of the Minimal Angle of Resolution) visual acuity before and after PRP; 2. Pearson's correlation test of total retinal blood flow with area of capillary drop-out on FA before and after PRP; 3. Pearson's correlation test of total retinal blood flow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-05-25 |
What the finished NCT01928550 record still lists
NCT01928550 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01928550 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01928550 about?
NCT01928550 is a clinical study titled "Diabetes PRP and OCT". The purpose of this study is to evaluate the effectiveness of investigational Doppler Optical Coherence Tomography (OCT) and OCT angiography in the management of proliferative diabetic retinopathy (PDR - a leading cause of blindness in diabetic patients) before and after treatment. Angiography is th...
What is the current status of trial NCT01928550?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2013-08. Estimated completion is 2016-05-25.
Who is sponsoring clinical trial NCT01928550?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia